There is no cure for autism, and autism is not an illness that research is trying to remove from everyone. It is a lifelong difference in how the brain develops, with a wide range of strengths and support needs. The U.S. National Institute of Mental Health says services and supports can improve health, well-being and daily functioning. Our view: the real progress is in earlier identification, therapies that build communication and daily skills, and better treatment of the conditions that often come with autism, such as sleep problems, anxiety and epilepsy.
This is Cure Checker's editorial assessment of published evidence, not medical advice. Decisions about therapies and medicines belong with the autistic person, their family and their care team.
Viewpoint: neurodiversity. Many autistic people and autistic-led groups see autism as a natural difference to be understood and supported rather than a disease to be cured. The Autistic Self Advocacy Network, run by and for autistic people, works for a world in which autistic people have equal access, rights and opportunities. In a 2024 survey of 225 autistic adults in Scotland, mental health, diagnosis and support services ranked as the most important research topics, and treatments, genetics and causes the least. Cure Checker reports these views and the evidence, and uses "autistic people" and "people with autism" as its sources do.
Newest first. Updated each week as results, trial launches and papers are published.
In 152 youth aged 5 to 17 with autism and irritability, caregiver-rated irritability fell more on cariprazine than on placebo after 8 weeks (a 3.7-point bigger drop on the irritability scale). Clinicians rated 68.9% as improved vs 38.0% on placebo. About half had side effects, mostly sleepiness and headache. It targets irritability, not core autism traits, and was an 8-week trial with authors who work for the maker, AbbVie.
Pooling 16 controlled studies with 703 children and teens, drama-based programs showed a medium boost in social skills (g = 0.54), but results varied a lot between studies. Setting and who delivered the program mattered.
In a trial of 236 youth aged 6-16, caregivers reported less irritability and hyperactivity after therapeutic horseback riding and after a barn activity without horse contact, compared with a waitlist. Riding did slightly better on hyperactivity. Results rest on caregiver reports, and the waitlist group was small (28).
Seven meta-analyses covering over 3 million people showed a small overall association, but it shrank toward none when only higher-quality, low-bias studies were used. The authors say the evidence does not support a causal link, and acetaminophen stays first-line in pregnancy.
In a 2-month trial of 62 children at one hospital in China, adding the diet to rehabilitation lowered rating-scale scores more than rehabilitation alone. The trial was small, short and not described as blinded.
Comparing 124,333 siblings, prenatal acetaminophen was not associated with autism (hazard ratio 1.00) or ADHD. Links seen in ordinary comparisons were likely due to family factors.
A follow-up analysis of 19 Brazilian children from a 12-week double-blind trial found no difference from placebo. The authors say it does not show a treatment effect.
In 61 children aged 8–17 over 8 weeks, overall severity, daily functioning and social responsiveness improved more than on placebo. Small, single-site and run by the company that makes it. A 200-person Phase 3 is planned.
A sham-controlled trial in 47 children found symptom scores improved more with the active stimulation at 1 and 4 weeks, with no serious side effects. The authors say clinical significance still needs testing.
Among 838,801 U.S. autistic children, prescriptions rose from about 34 to 835 per 100,000 visits by November 2025, after the September 2025 White House announcement, despite limited evidence.
A multicenter, masked, sham-controlled trial in China in children aged 4–10 found larger gains in social communication scores after treatment and 1 month later. Side effects were mild to moderate. Follow-up was only 1 month.
In a sham-controlled trial of 67 people aged 6–30 with cognitive or adaptive delays, 55% responded to active stimulation plus behavioral training versus 29% on sham.
The largest autism sequencing study in Latin American people (over 15,000 people, 4,717 autistic) found 35 autism-linked genes that overlap with European findings.
The Wellcovorin label now covers cerebral folate transport deficiency with a confirmed FOLR1 gene variant. The label does not mention autism.
The European Journal of Pediatrics retracted a 77-child randomized trial from 2024 that had been cited as evidence for leucovorin in autism.
In a small double-blind trial (35 analyzed, ages 8–17), 56% responded on memantine versus 21% on placebo. Needs a larger trial.
A Danish study of 1,224,176 children found no increase in autism, ADHD or 48 other chronic conditions with more vaccine aluminum.
An analysis of 5,392 autistic people in the SPARK study found four groups with different traits, each tied to different genetic patterns and timing of gene activity.
2022 data from 16 U.S. sites. Boys were identified 3.4 times as often as girls.
Two new double-blind Phase 2 trials: 150 children aged 3–6 in Israel (recruiting since June 2026) and 184 children aged 3–10 in Singapore.
Two trials of 160 children and teens aged 5–17 each are recruiting, with primary completion estimated for June 2027.
Two trials of 176 children and teens each are listed as not yet recruiting, with completion estimated for August 2029.
No treatment changes autism itself. What works is support that builds skills and communication, plus treatment of the specific problems that often come with autism. The best-tested approaches start early and involve the family.
A 2023 BMJ review of randomized trials found these play-based approaches, often coached through parents, improve social communication. The authors note that side effects were poorly tracked in most trials.
In a trial of 104 infants randomized at about 12 months, 6.7% of coached families' children met autism criteria at age 3, versus 20.5% with usual care. Larger studies are needed.
The only medicines FDA-approved for an autism-related symptom, irritability. They do not treat autism itself, and their side effects should be weighed with a doctor.
In a 13-week randomized trial of 125 children, it added about 33 minutes of sleep a night over placebo and helped children fall asleep faster.
Five days of stimulation improved social communication scores more than sham at 1 month. Long-term benefit and safety are unknown, and it is not an approved autism treatment.
The FDA approval covers FOLR1-related cerebral folate deficiency, not autism, and the largest autism trial was retracted in January 2026. New placebo-controlled trials should settle whether any autistic children benefit.
| Support | For | What it does |
|---|---|---|
| Screening and diagnosis (checks at 18 and 24 months; FDA-authorized diagnosis aids since 2021) | Young children | Finds autism early so support can start sooner. Adults can also be evaluated. |
| Behavioral, developmental and educational programs | Children, often with family involvement | Build social, communication, learning and daily-living skills. |
| Speech-language and occupational therapy | People with communication, motor or sensory needs | Support speech, alternative communication, sensory differences and daily tasks. |
| Medicines for specific symptoms | Irritability, anxiety, attention, sleep | Ease symptoms that get in the way of daily life. They don't change autism itself. |
| Care for co-occurring conditions | Sleep, GI, seizures, ADHD, anxiety | These are common with autism and are treated the same way as in anyone else. |
Nothing natural cures or prevents autism. A few approaches help with specific problems like sleep or motor skills. Many others are heavily marketed with weak evidence, and some are dangerous. We rate each by the strength of human evidence.
Randomized trials and a 2025 meta-analysis show it helps autistic children sleep longer, with mostly mild side effects. Use it with a doctor's guidance.
A September 2026 meta-analysis found exercise programs improved overall, gross and fine motor skills in autistic children.
An August 2026 meta-analysis of randomized trials found small, statistically significant benefits for irritability and communication. The authors call them clinically modest.
A 2024 meta-analysis of 8 small trials (318 people) found modest behavior improvements. Larger, better trials are needed.
A 2026 umbrella review found small overall improvements from diet changes and supplements, but none for repetitive behavior, irritability or lethargy.
In a 108-child trial, clinicians saw improvement but caregivers saw no difference from placebo. Unconfirmed.
Results are mixed: one small company-run trial was positive, and another small analysis found no benefit over placebo. Not approved for autism.
A Cochrane review found no evidence that it improves autism symptoms, and ear injuries can occur.
Dangerous, unproven "cures": chelation therapy has no proven benefit for autism, and chelation has caused deaths, including a 5-year-old autistic boy in 2005. "Miracle Mineral Solution" (chlorine dioxide) becomes a bleach-like chemical and can cause severe vomiting, dehydration and liver failure. Stem-cell products are not FDA-approved for autism and have caused infections, blindness and tumors. In December 2025 the FDA retired its 2017 consumer warning about false autism treatments such as chelation, hyperbaric oxygen and chlorine dioxide, but the evidence of harm has not changed. Tell your care team about everything you use.
Centers recognized for expertise in this condition, and communities of autistic people and families.
Says it is designated a National Institutes of Health Autism Center of Excellence (Duke is on NIH's 2022 award list). It runs the Duke Autism Clinic for evaluation and intervention.
Home of UNC's NIH Autism Center of Excellence, funded for four consecutive grant cycles. Its clinic sees people of all ages with, or suspected of having, developmental disabilities including autism.
Says it is a legacy Autism Care Network site, offering diagnosis, assessment, care coordination and sleep, genetics, neurology and GI care.
Says it is a field site in the Autism Care Network supported by Autism Speaks, with designated autism specialists and a focus on anxiety, ADHD, irritability and sleep.
These are centers recognized for expertise in this condition, not a ranking, and Cure Checker does not endorse or rate any facility. Outcomes depend on the individual. Ask your doctor which center fits your situation.
Autistic people, parents and caregivers can connect with others who understand. Some groups are run by autistic people themselves. Most are free.
State and local advocacy groups run by self-advocates with developmental disabilities, listed by the Autistic Self Advocacy Network. Groups must be active, meeting about once a month.
Find a group ↗About 70 local and state affiliates offer local services and supports. A state map lists each one's contact details.
Find an affiliate ↗Trained specialists connect you to resources and services in your area, by form or at 800-328-8476. It is not a crisis line; in a crisis in the U.S., call or text 988.
Contact the helpline ↗An online forum with over 3,500 active users, open 24 hours a day and moderated daily, with spaces for autistic adults, parents and carers.
Learn more ↗A long-running independent forum with active discussions and a parenting section. Some areas are for members or adults only.
Visit the forums ↗Member organizations offer information and one-to-one emotional support from trained parents who have been there. Not autism-only.
Find your state ↗Many parent and autistic-adult groups. This link searches Facebook (a login is required); Cure Checker hasn't checked the groups it shows.
Search Facebook ↗Before you join: support groups share experiences, not medical advice. Check anything about treatment with your doctor. Be wary of groups that promote "cures" or ask for money for unproven products. Think about your privacy and your child's, because many forums are public, and never share passwords or financial details. Cure Checker isn't affiliated with these groups.
No country has an approved medicine for autism itself. Approvals cover related problems, mainly irritability and sleep, and they differ from place to place. Support services matter more than medicines everywhere.
| Treatment | U.S. | EU | UK | Japan | Australia |
|---|---|---|---|---|---|
| RisperidoneIrritability / behavior with autism | 2006 | — | — | 2016 | Yes |
| AripiprazoleIrritability with autism | 2009 | — | — | 2016 | — |
| Prolonged-release melatonin (Slenyto)Sleep problems in autistic children | — | 2018 | Yes | — | — |
| LeucovorinRare folate disorder only | 2026, not for autism | — | — | — | — |
| Diagnosis aid devicesCanvas Dx, EarliPoint | 2021 | — | — | — | — |
Japan's regulator reviewed risperidone for irritability with autism in children in early 2016, and aripiprazole was approved for the same use on December 6, 2016.
Prolonged-release melatonin is a licensed medicine for insomnia in autistic children aged 2–18 when sleep routines haven't worked.
Risperdal's Australian approved uses include behavioral disorders associated with autism in children and adolescents.
Autism comes mostly from genes that shape how the brain develops before birth. Researchers don't know every cause, but large studies have ruled out vaccines and, in sibling comparisons, acetaminophen in pregnancy.
Live numbers and the newest entries from the world's main trial registries and medical databases. Most of this loads fresh each time you open the page.
Loading live data from ClinicalTrials.gov…
Loading…
Loading…
Loading…
| Medicine | Brand | FDA application | Original approval |
|---|
From Drugs@FDA via FDA's openFDA service. Some older brands are missing from FDA's open data, and newly approved drugs can take a few weeks to appear. An approval may be for a different disease than this one.
The WHO's ICTRP gathers trials from registries worldwide, including China, Japan, India, Iran, Australia and Brazil. Cochrane CENTRAL and OpenMD don't allow automated access, so they're linked here for you to search directly.
These nonprofits give grants, devices, safety items or scholarships to autistic people and families. Funds are limited, most programs open only at certain times of year, and rules vary, so contact each one directly.
A yearly family grant toward therapies, camp, recreation, safety items, social-skills training, software and advocacy. The 2026 round closed March 5; it usually opens in February. No amount is stated.
See the program ↗Up to $1,000 for music lessons, workshops, recording, music therapy and similar costs. Applications closed May 21, 2026 and are expected to reopen in April 2027.
See the grant ↗Provides iPads for communication (AAC) and other communication supports to people whose communication challenges put them at risk of harm. Funding is very limited; applications were open on October 6, 2026.
See the program ↗A free kit with door and window alarms, an ID bracelet or shoe tag, door prompts and safety guides, one per family. It was marked out of stock on October 6, 2026.
Check availability ↗Donates iPads each month (no apps loaded). Applications are taken online all year.
See the program ↗Partial or full scholarships to social-skills, equine or aquatic therapy camps (the 2026 round is closed), and holiday gift cards for randomly selected families, with applications November 2 to 16, 2026.
See the scholarships ↗$3,000 scholarships, including one for autistic students of color. Closed now; the next cycle opens in December 2026 for the 2027–28 school year.
See the scholarships ↗A $500 scholarship toward college costs, with an essay. The 2026 deadline (April 28) has passed.
See the scholarship ↗Before you apply: Cure Checker does not run, verify or endorse these organizations, and being listed is not a promise of help. Funds are limited and rules change, so confirm eligibility and details with each organization. Be careful of anyone who asks for payment up front or for your bank login to 'release' a grant.
Everything this report is based on, grouped by section. Checked October 6, 2026.
The list of traits, strengths and linked conditions, and the age-2 diagnosis point, come from NIMH; co-occurring conditions from the AAP clinical report. The figure of "over 1.8 million Danish children" adds the MMR (657,461) and aluminum (1,224,176) cohorts, which may overlap. Japan's exact risperidone approval date wasn't found (the review is dated January 15, 2016). Cells marked "—" mean no approval was found in our check, not a confirmed refusal; Slenyto is listed for the UK from its Great Britain licence, and EU/UK approvals of diagnosis devices weren't checked. The FDA's own 2019 warning on chlorine dioxide could not be opened, so a news report of it is cited; the FDA's December 2025 removal of its autism-products warning is from Disability Scoop. Several Latest-studies items rely on PubMed abstracts rather than full texts; the leucovorin retraction reason is from The Transmitter. Expert care centers: Autism Speaks blocks automated checks, so Autism Care Network membership is each center's own statement; NIH Autism Center of Excellence status comes from NICHD's September 6, 2022 award list (a new award round is under way in 2026). No verified center outside the U.S. was found. Support groups: no Reddit community is listed because Reddit blocked our checks and none could be confirmed; Autism Speaks and AANE support pages also blocked automated checks. Financial help: checked October 6, 2026. ACT Today! (Autism Care Today) could not be read because its site blocks automated checks, so it is not listed. No medical-cost charity (HealthWell, PAN Foundation, Patient Advocate Foundation) listed an autism fund. The UnitedHealthcare Children's Foundation and Small Steps in Speech give grants that can cover some autism-related care, but they aren't autism-specific, so they aren't listed. Several programs give no amount or service area; Joey's Fund is for New England only.